Overview

Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)

Status:
Completed
Trial end date:
2017-02-10
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, cross-over study, is to ascertain if ticagrelor, but not prasugrel or clopidogrel, is associated to an improved endothelial function as assessed with peripheral arterial tonometry and markers of endothelial function measurement in post-ACS patients.
Phase:
Phase 4
Details
Lead Sponsor:
Erasmus Medical Center
Collaborator:
Covance
Treatments:
Clopidogrel
Prasugrel Hydrochloride
Ticagrelor
Ticlopidine